Viewing StudyNCT02560532



Ignite Creation Date: 2024-05-06 @ 7:36 AM
Last Modification Date: 2024-10-26 @ 11:50 AM
Study NCT ID: NCT02560532
Status: COMPLETED
Last Update Posted: 2018-07-10
First Post: 2015-09-23

Brief Title: Evaluation of the Efficacy and Safety of Clazosentan in Reversing Cerebral Vasospasm in Adult Subjects With Aneurysmal Subarachnoid Hemorrhage
Sponsor: Idorsia Pharmaceuticals Ltd
Organization: Idorsia Pharmaceuticals Ltd

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-03-01
Start Date Type: None
Primary Completion Date: 2017-05-02
Primary Completion Date Type: ACTUAL
Completion Date: 2017-05-02
Completion Date Type: ACTUAL
First Submit Date: 2015-09-23
First Submit QC Date: September 24 2015
Study First Post Date: 2015-09-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-07-06
Last Update Post Date: 2018-07-10
Last Update Post Date Type: ACTUAL